Sarepta Therapeutics Inc (NASDAQ: SRPT): The Best-Of-Breed For Investing?
Currently, there are 98.25M common shares owned by the public and among those 93.37M shares have been available to trade. The company’s stock has a 5-day price change of -9.36% and -75.13% over the past three months. SRPT shares are trading -84.63% year to date (YTD), with the 12-month market performance down to -84.39% lower. […]
Sarepta Therapeutics Inc (NASDAQ: SRPT) Not A Good Play Anymore?
Sarepta Therapeutics Inc (SRPT) concluded trading on Thursday at a closing price of $37.31, with 3.19 million shares of worth about $119.07 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -71.08% during that period and on June 12, 2025 the price saw a […]
Is Sarepta Therapeutics Inc (NASDAQ: SRPT) Back In The Buying Zone?
Currently, there are 98.25M common shares owned by the public and among those 93.39M shares have been available to trade. The company’s stock has a 5-day price change of 10.47% and -62.67% over the past three months. SRPT shares are trading -67.11% year to date (YTD), with the 12-month market performance down to -69.87% lower. […]
Sarepta Therapeutics Inc (NASDAQ: SRPT) Has Another Chance To Impress You
Currently, there are 96.90M common shares owned by the public and among those 92.29M shares have been available to trade. The company’s stock has a 5-day price change of -23.17% and -59.02% over the past three months. SRPT shares are trading -61.55% year to date (YTD), with the 12-month market performance down to -64.21% lower. […]
Sarepta Therapeutics Inc (NASDAQ: SRPT): The Best-Of-Breed For Investing?
The Vanguard Group, Inc. recently announced the acquisition of new stake in Sarepta Therapeutics Inc (NASDAQ:SRPT). The institutional investor has increased its shareholding in the Healthcare company by 0.46% to 8.45 million shares with purchase of 38383.0 shares. This fresh investment now brings its stake to 9.03% valued currently at $686.45 million. In addition, Janus […]